NCCN Guidelines Insights: Prostate Cancer, Version 1.2021.
J Natl Compr Canc Netw
; 19(2): 134-143, 2021 02 02.
Article
en En
| MEDLINE
| ID: mdl-33545689
The NCCN Guidelines for Prostate Cancer address staging and risk assessment after a prostate cancer diagnosis and include management options for localized, regional, and metastatic disease. Recommendations for disease monitoring and treatment of recurrent disease are also included. The NCCN Prostate Cancer Panel meets annually to reevaluate and update their recommendations based on new clinical data and input from within NCCN Member Institutions and from external entities. This article summarizes the panel's discussions for the 2021 update of the guidelines with regard to systemic therapy for metastatic castration-resistant prostate cancer.
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Neoplasias de la Próstata
Tipo de estudio:
Diagnostic_studies
/
Etiology_studies
/
Guideline
/
Qualitative_research
/
Risk_factors_studies
Límite:
Humans
/
Male
Idioma:
En
Revista:
J Natl Compr Canc Netw
Asunto de la revista:
NEOPLASIAS
Año:
2021
Tipo del documento:
Article